|
|
|
Volumn 4, Issue 10, 2006, Pages 722-729
|
|
Recent advances in the treatment of APL
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
CD33 ANTIGEN;
DAUNORUBICIN;
GEMTUZUMAB OZOGAMICIN;
MERCAPTOPURINE;
METHOTREXATE;
PROMYELOCYTIC LEUKEMIA PROTEIN;
RETINOIC ACID;
RETINOIC ACID RECEPTOR;
ORGANOARSENIC DERIVATIVE;
OXIDE;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ANTIGEN EXPRESSION;
ARTICLE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BLEEDING;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CHROMOSOME ANALYSIS;
CHROMOSOME TRANSLOCATION;
CLINICAL TRIAL;
DIAGNOSTIC VALUE;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SENSITIVITY;
DRUG TOLERABILITY;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENE REARRANGEMENT;
HUMAN;
LEUKEMIA RELAPSE;
LEUKEMIA REMISSION;
LOW DRUG DOSE;
MAINTENANCE THERAPY;
MINIMAL RESIDUAL DISEASE;
POLYMERASE CHAIN REACTION;
PROMYELOCYTIC LEUKEMIA;
RECURRENCE RISK;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RISK REDUCTION;
DIFFERENTIAL DIAGNOSIS;
GENE TRANSLOCATION;
GENETICS;
HISTORY;
REVIEW;
ANTINEOPLASTIC AGENTS;
ARSENICALS;
DIAGNOSIS, DIFFERENTIAL;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
OXIDES;
TRANSLOCATION, GENETIC;
|
|
EID: 33751259562
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (6)
|
